The United Nations has declared that women’s rights are facing a global backlash affecting both public and private spheres, online and off. So, what is Canada, as a notable human rights leader, doing to progress women’s rights? In the spring of 2025, the Honourable Rechie Valdez became Minister of Women and Gender Equality (WAGE), thus reigniting hope for Canadian women in achieving substantive gender equality. In 2025 parliamentarians introduced several new bills in the Senate and House of Commons that would respect, protect and fulfill women’s human rights, as per international standards. As human rights are interrelated and interdependent, these bills, which focus on the health and safety of women, would operate collectively to reduce morbidity and mortality rates.
The objective of this two-part article is not to replicate or replace research done by healthcare specialists or advocacy organizations, but rather to provide insight into the international legal framework that applies to the pertinent legislation. This article highlights the international commitments made by Canada to ensure the health of women. But health must be thought of as extending to both physical and psychological states. A woman who is perpetually unsafe or in a state of fear is at risk of compromised health, beyond physical injury resulting directly from violence. To that effect, legislation focused on providing safety for women through protection for victims of gender-based violence, will follow in an upcoming article.

Part I – Health:
The right to adequate health is a global norm in international human rights law. Since 1976, Canada has been a State party to the International Covenant on Economic, Social and Cultural Rights (ICESCR), which mandates the right to heath.[i]
Article 12
1. The States Parties to the present Covenant recognize the right of everyone to the enjoyment of the highest attainable standard of physical and mental health.
2. The steps to be taken by the States Parties to the present Covenant to achieve the full realization of this right shall include those necessary for:
(a) The provision for the reduction of the stillbirth-rate and of infant mortality and for the healthy development of the child;
(b) The improvement of all aspects of environmental and industrial hygiene;
(c) The prevention, treatment and control of epidemic, endemic, occupational and other disease
(d) The creation of conditions which would assure to all medical service and medical attention in the event of sickness.
Article 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR) is subject to the principle of non-discrimination. However, women have been significantly underrepresented in health research for decades, thereby creating sex and gender-based disparities in health outcomes. Those disparities in turn create barriers to the enjoyment of other fundamental rights, including the right to education, the right to work, the right to political participation, and the right to life – the foundation of all other rights and fundamental freedoms.
The right to life, proscribed under Article 6 of the International Covenant on Civil and Political Rights, carries both positive and negative obligations owed by the State party – the negative obligation to respect life by abolishing arbitrary killings, the positive obligations to protect life from threats by third parties, and by fulfilling certain conditions necessary to sustain life.
The following bills, by remediating historical health inequities, could progress women’s substantive equality by fulfilling conditions necessary for their enjoyment of the right to life with dignity.
Bill S-204: National Framework on Heart Failure Act[ii]
An Act to establish a national framework on heart failure
Sponsored by the Honourable Senator Yonah Martin
First reading: May 28, 2025
Second reading: December 9, 2025
Assigned to the Senate Committee on Social Affairs, Science and Technology for study.
The preamble of Bill S-204 recognizes that, “…Whereas heart failure is the third-leading cause of hospitalization in Canada — following childbirth and chronic obstructive pulmonary disease (COPD) — and remains a leading cause of death, particularly among women, for whom it is second only to cancer and ischemic heart disease”.
Bill S-204 would require that the Minister of Health “develop a national framework to support improved access to heart failure prevention, diagnosis, management and evaluation to ensure better health outcomes…”[iii].
The Heart and Stroke Foundation of Canada reports that heart disease and stroke are the primary cause of premature death for women in Canada, yet two thirds of clinical research on heart disease and stroke have been focused on men. Using the average male body as the prototypical patient ignores the evidence that many conditions present differently in females and some gender diverse persons – heart attacks are one example and those differences are costing women their lives.
While Bill S-204 does not explicitly name women outside of the Preamble, the Content section,(paragraph 2 (a)), provides that the framework “ensure equitable access across all demographics and regions”. Additionally, Bill S-243, an Act to establish a national framework for women’s health in Canada, if passed would complement Bill S-204.
Bill S-243: National Framework for Women’s Health in Canada Act[iv]
An Act to establish a national framework for women’s health in Canada
Sponsored by the Honourable Senator Danièle Henkel
First reading December 9, 2025
Debate at second reading in Senate: As of February 5, 2026
Bill S-243 provides the support necessary for the Minster of Health to develop a national framework to “support improved health outcomes and health access for women, equitable investment in women’s health research and innovation and health-focused entrepreneurship driven by women”[v].
(International Legal scope follows “The necessity”)

The necessity
Although women live longer on average than men,[vi] Canadian women spend 24% more time living in poor health and disability than men.[vii] Health issues that exclusively or disproportionately affect women, are significantly under-funded, under-researched, and under-treated. For example, 80% of individuals with an autoimmune disease are women, yet twice as many male participants are used in clinical trials. Furthermore, Harvard Health reports that “70% of those affected by chronic pain are women, whereas 80% of pain research is conducted on males”.(sic)[viii]
In research and health care, sex matters (although not exclusively). The female body is a complex, dynamic system of inter-related structural and physiological systems including sex-specific hormones and chromosomes, distinct from males and therefore requiring specific research.
Most research on female health has focused primarily on sexual and reproductive health and maternal, newborn and child health. Only recently have conditions such as endometriosis, adenomyosis, polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovarian syndrome (PCOS), premenstrual dysphoric disorder (PMDD), pelvic floor dysfunction and other conditions of the female reproductive system, become more broadly recognized. With scant research, millions of reproductive age women and gender diverse persons suffer in pain for years before even receiving an accurate diagnosis.
Menopause, additionally, has been ignored in 99% of pre-clinical age-related studies[ix], despite being inextricably linked to aging in females. Menopause is also strongly associated with different types of dementia, including vascular dementia and Alzheimer’s. “Alzheimer’s Disease (AD) is marked by pronounced sex differences in pathophysiology and progression.” According to the Alzheimer’s Society, around twice as many women have AD than men. However, clinical trials in AD include eight times more male participants than female participants.[x]

In Canada women were routinely excluded from clinical trials until 1997. According to Global Data Healthcare, drug interactions, optimum dosage and side effects of pharmaceutical treatments may differ according to the sex of the patient, yet females are underrepresented in phase 1 clinical trials of pharmaceuticals.[xi]
Trial participation matters because in cancer, for example, “multiple bodily factors contribute to how the disease develops, progresses and responds to treatment, and many of these factors relate to sex. (…) Between 2003 and 2016, females represented less than 10 per cent of participants in lung and pancreatic cancer trials, despite accounting for more than 40 per cent of the diagnoses.”[xii] Additionally, while 20% of all cancer research funding goes to breast cancer, comparatively, funding for gynecological cancers – cervical, ovarian and uterine – are consistently underfunded despite their higher mortality rates. Breast cancer now has a 5-year survival rate of 89%, whereas the ovarian cancer survival rate is only 44%[xiii].
Furthermore, chronic pain conditions are also impacted by the gender health gap. A data analysis conducted between 2004 – 2018 on over 20,000 individuals with fibromyalgia, found that 88.8% of the sufferers were women and the mean age was 48.[xiv] Fibromyalgia is one of the most underfunded diseases per patient, worldwide. Its root causes are still poorly understood and overlapping comorbidities make it difficult to diagnose and prone to stigmatization. Thus treatment is limited to alleviating the symptoms, which include debilitating widespread chronic pain, fatigue and cognitive dysfunction, without addressing a root cause.
Other underfunded, female dominant conditions include myalgic encephalomyelitis (formerly chronic fatigue syndrome), headaches, migraine, osteoporosis and eating disorders.[xv] Migraine, for example, is twice as prevalent in females as in males, which is thought to be explained by sex hormones, and therefore a ‘woman’s disease’. That gender bias and stigmatization of migraine is further perpetuated by the funding disparity.[xvi]
Lack of understanding and lack of funding is a vicious, self-perpetuating circle. Evidently, more must be done to ensure health research into conditions and diseases unique to or disproportionately impacting women. Additionally, with multiple factors affecting women’s health, there is a need for diverse disaggregation of data using both sex and gender[xvii], as well as age and other characteristics, such as ethnicity and socio-economic status. This intersectional data collection would allow healthcare to truly move beyond the ‘one-size fits all’ approach, and even beyond a binary approach.
Where there is insufficient data or research, there is no adequate treatment or, significantly, prevention for disease. Consequentially, the substantive inequalities in health care create significant barriers from obtaining substantive equality in other rights-based contexts, such as the right to education, to work, to political participation, and the right to life.

International legal scope
In 2000 the UN Committee on Economic, Social and Cultural Rights published its General Comment No. 14, clarifying the scope of Article 12 on the right to health, under the International Covenant on Economic, Social and Cultural Rights . Recognizing the structural inequality in health care, the Committee emphasized the need for a national action plan to fulfill women’s right to health. That recommendation was over 25 years ago.
21. To eliminate discrimination against women, there is a need to develop and implement a comprehensive national strategy for promoting women’s right to health throughout their life span. Such a strategy should include interventions aimed at the prevention and treatment of diseases affecting women, as well as policies to provide access to a full range of high quality and affordable health care, including sexual and reproductive services. A major goal should be reducing women’s health risks, particularly lowering rates of maternal mortality and protecting women from domestic violence.[xviii]
The Committee articulated the requirement for a gendered perspective. (At the time, sex and gender were frequently conflated as being synonymous.) [xix]
20. The Committee recommends that States integrate a gender perspective in their health-related policies, planning, programmes and research in order to promote better health for both women and men. A gender-based approach recognizes that biological and socio-cultural factors play a significant role in influencing the health of men and women. The disaggregation of health and socio-economic data according to sex is essential for identifying and remedying inequalities in health.
According to the WHO’s 2024 report on Health Inequality Monitoring, data “can be said to be disaggregated when they are broken down according to a dimension of inequality.” Therefore, using both sex and gender disaggregated data[xx],as they are not synonymous, would be most conducive to an intersectional approach while fulfilling the UN legal criteria. Additionally, this approach aids the World Health Organization (WHO), the Organization for Economic Co-operation and Development (OECD) and other global NGOs in their research.

Canada is also a State party to the Convention on the Elimination of All forms of Discrimination Against Women (CEDAW), which it ratified in 1981. The CEDAW Committee’s General Recommendation No. 24 (on) Article 12 of the Convention, adopted in 1999, states the following:
11. Measures to eliminate discrimination against women are considered to be inappropriate if a health-care system lacks services to prevent, detect and treat illnesses specific to women.[xxi]
The CEDAW Committee provided the following recommendations for government policy that would considers women’s health at all stages of life.
29. States parties should implement a comprehensive national strategy to promote women’s health throughout their lifespan. This will include interventions aimed at both the prevention and treatment of diseases and conditions affecting women, as well as responding to violence against women, and will ensure universal access for all women to a full range of high-quality and affordable health care, including sexual and reproductive health services.
To that effect, States have only recently begun to facilitate support for menopause, due in part to the rising number of women living longer. (see Figure 1) Age is one of the protected characteristics increasingly recognized throughout human rights legal instruments. It is reiterated in CEDAW’s General Recommendation No. 27 on older women and protection of their human rights (2010) as “one of the grounds on which women may suffer multiple forms of discrimination”, [xxii] thereby recommending that statistical data on menopause be age and sex disaggregated.

Figure 1: Absolute numbers of women in menopausal transition (45-60 years) according to world regions between 1951 and 2021 (source: United Nations 2022).
Additionally, CEDAW recommends the following, according to the principle of non-discrimination.
30. States parties should allocate adequate budgetary, human and administrative resources to ensure that women’s health receives a share of the overall health budget comparable with that for men’s health, taking into account their different health needs.

Conclusion:
The right to health is a collective human right that States have committed to respect, protect and fulfil. Furthermore, it is linked to the right to life, which is necessary for the enjoyment of all other human rights.
In January of 2025 the World Economic Forum in collaboration with McKinsey Health Institute, a think-tank on global economic healthcare trends, produced the insight report Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All. The key insight was that addressing nine specific conditions could increase the global GDP by $400 billion by 2040. [xxiii]
On October 22, 2025, an article by the McKinsey Health Institute reported that closing the women’s health gap in Canada could “potentially boost the country’s economy by $30 billion annually by 2040”[xxiv]. As Canadian sovereignty is under attack through financial coercion, this is a catalyst incentivizing the government to support women’s healthcare. Improved healthcare also affects an individual’s overall lifetime earnings, decreasing income disparity, and thereby improving a woman’s individual ability to thrive.
In 1986 the UN General Assembly adopted the Declaration on the Right to Development (resolution 41/128). It reminded States that the objective of development is for the “constant improvement of the well-being of the entire population and of all individuals on the basis of their active, free and meaningful participation in development and in the fair distribution of benefits resulting therefrom”[xxv]. That message has been largely forgotten.
Although both the right to development and the right to health are subject to progressive development, the world is decades behind in progress for those rights benefiting women equally in comparison to men, contrary to the principle of non-discrimination. To address structural barriers, women’s equality rights must exist not just on paper, but in practice, with State support.
(Subscribe at the link on the bottom of page for the Part II of this article, on legislation addressing women’s safety.)
Call to Action
After reviewing the text of a bill, there are two options to participate in the process of supporting it.
Bill S-204: National Framework on Heart Failure Act
Bill S-243:National Framework for Women’s Health in Canada Act
Write a letter to your Member of Parliament (recommended for everyone):
- Expressing your opinions, personal experiences, recommendations, or legal arguments for or against a bill
- Find your MP here: https://www.ourcommons.ca/members/en/search
- Your contact information must be included, as this determines your riding and legitimizes your communication
Write a letter to a Senator that represents your province:
- Expressing your opinions, personal experiences, recommendations, or legal arguments for or against a bill
- Find your provincial Senators here: https://sencanada.ca/en/senators/
- Your contact information must be included, as this determines your riding and legitimizes your communication
Submit a brief to a Senate Committee
(recommended for organizations and knowledgeable individuals):
“Senate committees regularly invite individuals, experts, groups and organizations, lobbyists, public servants and ministers of the Crown to appear before them as witnesses to receive information relevant to a bill they are considering or a special study they are undertaking. There are two ways to participate in a committee’s study: by giving oral evidence (testimony) or by submitting a brief (written evidence).”
[i] International Covenant on Civil and Political Rights, 1966, United Nations. https://www.ohchr.org/en/instruments-mechanisms/instruments/international-covenant-economic-social-and-cultural-rights
[ii] National Framework on Heart Failure Act, Bill S-204 – First Session, Forty-fifth Parliament, Senate of Canada; 2025.
https://www.parl.ca/legisinfo/en/bill/45-1/s-204
[iii] Para. 3 (1) Development; National Framework on Heart Failure Act, Bill S-204 – First Session, Forty-fifth Parliament, Senate of Canada; 2025. https://www.parl.ca/documentviewer/en/45-1/bill/S-204/first-reading
[iv] National Framework for Women’s Health in Canada Act; Bill S-243; 1st Session, 45th Parliament, Senate of Canada; 2025. https://www.parl.ca/legisinfo/en/bill/45-1/s-243
[v] Para. 2 (1) Development; pg. 2, National Framework for Women’s Health in Canada Act; Bill S-243; 1st Session, 45th Parliament, Senate of Canada; 2025. https://www.parl.ca/DocumentViewer/en/45-1/bill/S-243/first-reading
[vi] Differences across the lifespan between females and males in the top 20 causes of disease burden globally: a systematic analysis of the Global Burden of Disease Study 2021; Volume 9, Issue 5, May 2024; The Lancet; Vedavati Patwardhan, PhDa∙ Gabriela F Gil, MPHb ∙ Alejandra Arrieta, MIDPb ∙ Jack Cagney, MScb ∙ Erin DeGraw, MPHb ∙ Molly E Herbert, MScb ∙ et al.
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00053-7/fulltext
[vii] McKinsey Health Institute; Closing the women’s health gap: Canada’s $37 billion opportunity. (October 22, 2025). https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-canadas-37-billion-dollars-opportunity
[viii] Harvard Health Publishing; Women and pain: Disparities in experience and treatment (Nov. 9, 2017) https://www.health.harvard.edu/blog/women-and-pain-disparities-in-experience-and-treatment-2017100912562
[ix] Gilmer, G., Hettinger, Z.R., Tuakli-Wosornu, Y. et al. Female aging: when translational models don’t translate. Nature Aging , 1500–1508 (Dec. 5, 2023). https://doi.org/10.1038/s43587-023-00509-8
[x] GlobalData Healthcare; Women are underrepresented in trials for conditions that predominately affect them; June 26, 2023. https://www.clinicaltrialsarena.com/analyst-comment/women-underrepresented-trials-conditions/?cf-view
[xi] Ibid.
[xii] We can’t defeat cancer without acknowledging the differences between men and women; Isy Godfrey; October 24, 2023; The Institute of Cancer Research. https://www.icr.ac.uk/research-and-discoveries/cancer-blogs/detail/science-talk/we-can-t-defeat-cancer-without-acknowledging-the-differences-between-men-and-women
[xiii] Cancer-specific stats 2025; Canadian Cancer Society in collaboration with the Government of Canada. https://cdn.cancer.ca/-/media/files/research/cancer-statistics/2025-statistics/2025_cancer-specific-stats.pdf?rev=659842a56b7748129ca562088cc7e971&hash=BF1A42D8561EC68D584500DD0F2FAF23&_gl=1*6gg2kk*_gcl_au*MTI4ODA2NjE5MS4xNzY5ODI3Mjc1
[xiv] Exploring gender differences, medical history, and treatments used in patients with fibromyalgia in the UK using primary-care data: a retrospective, population-based, cohort study. The Lancet Rheumatology; Vo. 4, Sup. 1, September 2022, Page S20; Cardiff U.K. https://www.sciencedirect.com/science/article/abs/pii/S266599132200296X
[xv] Mirin AA. Gender Disparity in the Funding of Diseases by the U.S. National Institutes of Health. J Women’s Health (Larchmt). 2021 Jul;30(7):956-963. doi: 10.1089/jwh.2020.8682. Epub 2020 Nov 27. PMID: 33232627; PMCID: PMC8290307. https://pmc.ncbi.nlm.nih.gov/articles/PMC8290307/
[xvi] Casas-Limón J, Quintas S, López-Bravo A, Alpuente A, Andrés-López A, Castro-Sánchez MV, Membrilla JA, Morales-Hernández C, González-García N, Irimia P. Unravelling Migraine Stigma: A Comprehensive Review of Its Impact and Strategies for Change. J Clin Med. 2024 Sep 3;13(17):5222. doi: 10.3390/jcm13175222. PMID: 39274435; PMCID: PMC11396411. https://pmc.ncbi.nlm.nih.gov/articles/PMC11396411/#sec5-jcm-13-05222
[xvii] It “is important to highlight is the divergent terminology of sex and gender which, conventionally, are mistakenly used as synonyms. Sex refers to the biological and genetic features of individuals, whereas gender is intended as the social perspective of human beings concerning expressions, behaviors, and social roles. The latter is considered a personal choice and can generate a nonbinary range of gender identities.” Tokatli, M. R., Sisti, L. G., Marziali, E., Nachira, L., Rossi, M. F., Amantea, C., Moscato, U., & Malorni, W. (2022). Hormones and Sex-Specific Medicine in Human Physiopathology. Biomolecules, 12(3), 413. https://doi.org/10.3390/biom12030413
[xviii] E/C.12/2000/4: General Comment No. 14 on the highest attainable standard of health (2000), The Committee on Economic, Social and Cultural Rights https://www.ohchr.org/en/documents/general-comments-and-recommendations/ec1220004-general-comment-no-14-highest-attainable
[xix] “Gender interacts with but is different from sex. The two terms are distinct and should not be used interchangeably. It can be helpful to think of sex as a biological characteristic and gender as a social construct. Gender and Health, questions and answers”; 24 May 2021; https://www.who.int/news-room/questions-and-answers/item/gender-and-health
[xx] “Gender interacts with but is different from sex. The two terms are distinct and should not be used interchangeably. It can be helpful to think of sex as a biological characteristic and gender as a social construct. Gender and Health, questions and answers”; 24 May 2021; https://www.who.int/news-room/questions-and-answers/item/gender-and-health
[xxi] CEDAW General Recommendation No. 24: Article 12 of the Convention (Women and Health)
Adopted at the Twentieth Session of the Committee on the Elimination of Discrimination against Women; 1999 (Contained in Document A/54/38/Rev.1, chap. I)
[xxii] Paragraph 2; General recommendation No. 27 on older women and protection of their human rights UN. Committee on the Elimination of Discrimination against Women; 2010; CEDAW/C/GC/27; https://digitallibrary.un.org/record/711348?ln=en&v=pdf
[xxiii] World Economic Forum. (2025, January). Blueprint to Close the Women’s Health Gap: How to Improve Lives and Economies for All. https://www.weforum.org/publications/blueprint-to-close-the-women-s-health-gap-how-to-improve-lives-and-economies-for-all/
[xxiv] Closing the women’s health gap: Canada’s $37 billion opportunity. McKinsey Health Institute; October 22, 2025. https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-canadas-37-billion-dollars-opportunity
[xxv] Declaration on the Right to Development; UNGA 41/128, adopted December 4, 1986. https://www.ohchr.org/en/instruments-mechanisms/instruments/declaration-right-development









